VCEL (Vericel) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 27, 2026)


VCEL Vericel Corp VCEL
81 GF Score
Price $46.23
GF Value $54.29
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Vericel Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Vericel's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

VCEL vs PVLA, TSHA, GENB: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Vericel's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vericel Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vericel's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Vericel's Margin of Safety % (DCF FCF Based) falls into.


VCEL
81GF Score
Vericel Corp VCEL
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vericel (VCEL) Overvalued in 2026?

Based on GuruFocus' analysis, Vericel stock appears to be undervalued. The current stock price of $46.23 is trading 14.8% below its estimated GF Value™ of $54.29. GuruFocus considers Vericel to be Modestly Undervalued.

Key valuation signals for VCEL:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $54.29 vs. price of $46.23 (14.8% below fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the VCEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vericel Business Description

Other Exchanges ATQP:Germany
Address 64 Sidney Street, Cambridge, MA, USA, 02139
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
81GF Score

Get the complete analysis for VCEL

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$46.23
Price
$54.29
GF Value